Bal Pharma Limited (BALPHARMA.BO)
INR 120.0
(-0.87%)
INR 120.0
(-0.87%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 4.94 INR | 201.22% |
| 2022 | 1.64 INR | -56.73% |
| 2021 | 3.79 INR | 13.47% |
| 2020 | 3.34 INR | 138.75% |
| 2019 | -8.62 INR | -422.85% |
| 2018 | 2.67 INR | 36.22% |
| 2017 | 1.96 INR | 58.06% |
| 2016 | 1.24 INR | 13.76% |
| 2015 | 1.09 INR | -61.48% |
| 2014 | 2.83 INR | -40.67% |
| 2013 | 4.77 INR | 17.78% |
| 2012 | 4.05 INR | 13.45% |
| 2011 | 3.57 INR | 693.33% |
| 2010 | 0.45 INR | 133.09% |
| 2009 | -1.36 INR | -147.72% |
| 2008 | 2.85 INR | 4.01% |
| 2007 | 2.74 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.16 INR | -95.71% |
| 2023 Q1 | 0.76 INR | -25.49% |
| 2023 Q2 | 0.60 INR | -21.05% |
| 2023 Q3 | 0.56 INR | -6.67% |
| 2023 Q4 | 3.73 INR | 566.07% |
| 2023 FY | - INR | 201.22% |
| 2022 FY | - INR | -56.73% |
| 2022 Q4 | 1.02 INR | 161.54% |
| 2022 Q3 | 0.39 INR | 432.06% |
| 2022 Q2 | 0.07 INR | -92.28% |
| 2022 Q1 | 0.95 INR | -28.57% |
| 2021 Q4 | 1.33 INR | 315.63% |
| 2021 Q3 | 0.32 INR | -67.01% |
| 2021 Q2 | 0.97 INR | -11.01% |
| 2021 FY | - INR | 13.47% |
| 2021 Q1 | 1.09 INR | -56.75% |
| 2020 Q2 | 0.30 INR | 0.0% |
| 2020 FY | - INR | 138.75% |
| 2020 Q3 | 0.28 INR | -6.67% |
| 2020 Q4 | 2.52 INR | 800.0% |
| 2020 Q1 | 0.30 INR | 0.0% |
| 2019 FY | - INR | -422.85% |
| 2019 Q2 | -1.29 INR | 20.37% |
| 2019 Q1 | -1.62 INR | 0.0% |
| 2019 Q3 | -2.52 INR | -95.35% |
| 2019 Q4 | - INR | 100.0% |
| 2018 Q4 | - INR | -100.0% |
| 2018 Q2 | -0.53 INR | -147.32% |
| 2018 FY | - INR | 36.22% |
| 2018 Q1 | 1.12 INR | 566.67% |
| 2018 Q3 | 1.12 INR | 311.32% |
| 2017 FY | - INR | 58.06% |
| 2017 Q4 | -0.24 INR | 0.0% |
| 2016 Q3 | 0.43 INR | 258.33% |
| 2016 FY | - INR | 13.76% |
| 2016 Q4 | -1.29 INR | -400.0% |
| 2016 Q2 | 0.12 INR | 200.0% |
| 2016 Q1 | 0.04 INR | 101.97% |
| 2015 Q4 | -2.03 INR | -233.55% |
| 2015 FY | - INR | -61.48% |
| 2015 Q1 | -2.44 INR | 0.0% |
| 2015 Q2 | 1.52 INR | 162.3% |
| 2015 Q3 | 1.52 INR | 0.0% |
| 2014 Q1 | 0.78 INR | 0.0% |
| 2014 Q4 | - INR | -100.0% |
| 2014 Q3 | 0.81 INR | -38.64% |
| 2014 FY | - INR | -40.67% |
| 2014 Q2 | 1.32 INR | 69.23% |
| 2013 Q1 | 0.86 INR | 0.0% |
| 2013 Q4 | - INR | -100.0% |
| 2013 FY | - INR | 17.78% |
| 2013 Q2 | 1.33 INR | 54.65% |
| 2013 Q3 | 1.32 INR | -0.75% |
| 2012 Q2 | 0.88 INR | 388.89% |
| 2012 Q1 | 0.18 INR | 0.0% |
| 2012 Q3 | 0.99 INR | 12.5% |
| 2012 Q4 | - INR | -100.0% |
| 2012 FY | - INR | 13.45% |
| 2011 Q3 | 1.24 INR | 103.28% |
| 2011 Q4 | - INR | -100.0% |
| 2011 FY | - INR | 693.33% |
| 2011 Q2 | 0.61 INR | 0.0% |
| 2010 FY | - INR | 133.09% |
| 2009 FY | - INR | -147.72% |
| 2008 FY | - INR | 4.01% |
| 2007 FY | - INR | 0.0% |